Characterization of the interaction between human respiratory syncytial virus and the cell cycle in continuous cell culture and primary human airway epithelial cells.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 3196461)

Published in J Virol on July 27, 2011

Authors

Weining Wu1, Diane C Munday, Gareth Howell, Gareth Platt, John N Barr, Julian A Hiscox

Author Affiliations

1: Institute of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, UK.

Articles citing this

Respiratory syncytial virus modifies microRNAs regulating host genes that affect virus replication. J Gen Virol (2012) 1.01

Viral degradasome hijacks mitochondria to suppress innate immunity. Cell Res (2013) 0.99

The interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biology. J Virol (2012) 0.94

Phenol-soluble modulin α induces G2/M phase transition delay in eukaryotic HeLa cells. FASEB J (2015) 0.83

Staphylococcus aureus-induced G2/M phase transition delay in host epithelial cells increases bacterial infective efficiency. PLoS One (2013) 0.82

Murine norovirus replication induces G0/G1 cell cycle arrest in asynchronously growing cells. J Virol (2015) 0.82

Human respiratory syncytial virus non-structural protein NS1 modifies miR-24 expression via transforming growth factor-β. J Gen Virol (2015) 0.81

Differential Susceptibilities of Human Lung Primary Cells to H1N1 Influenza Viruses. J Virol (2015) 0.79

Overexpression of FABP3 inhibits human bone marrow derived mesenchymal stem cell proliferation but enhances their survival in hypoxia. Exp Cell Res (2014) 0.78

Induction of DNA double-strand breaks and cellular senescence by human respiratory syncytial virus. Virulence (2016) 0.78

Involvement of miR-15a in G0/G1 Phase Cell Cycle Arrest Induced by Porcine Circovirus Type 2 Replication. Sci Rep (2016) 0.76

The Role of Sialic Acid-Binding Receptors (Siglecs) in the Immunomodulatory Effects of Trypanosoma cruzi Sialoglycoproteins on the Protective Immunity of the Host. Scientifica (Cairo) (2013) 0.75

A comparison of host gene expression signatures associated with infection in vitro by the Makona and Ecran (Mayinga) variants of Ebola virus. Sci Rep (2017) 0.75

A network flow approach to predict protein targets and flavonoid backbones to treat respiratory syncytial virus infection. Biomed Res Int (2015) 0.75

Articles cited by this

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell (1993) 33.20

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev (1998) 12.55

Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol (1995) 7.57

Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev (1997) 5.22

Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J Virol (1995) 3.69

Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol (2003) 2.45

The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat Cell Biol (2000) 2.36

Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J Virol (2002) 1.92

The paramyxovirus simian virus 5 V protein slows progression of the cell cycle. J Virol (2000) 1.85

Herpes simplex virus type 1 immediate-early protein Vmw110 inhibits progression of cells through mitosis and from G(1) into S phase of the cell cycle. J Virol (1999) 1.66

Formation of mobile chromatin-associated nuclear foci containing HIV-1 Vpr and VPRBP is critical for the induction of G2 cell cycle arrest. PLoS Pathog (2010) 1.65

G2/M cell cycle arrest in the life cycle of viruses. Virology (2007) 1.39

Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis. Oncogene (2005) 1.39

Reovirus-induced G(2)/M cell cycle arrest requires sigma1s and occurs in the absence of apoptosis. J Virol (2000) 1.31

Influenza A virus replication induces cell cycle arrest in G0/G1 phase. J Virol (2010) 1.30

Cell cycle arrest in G2/M promotes early steps of infection by human immunodeficiency virus. J Virol (2005) 1.30

Distinct gene subsets are induced at different time points after human respiratory syncytial virus infection of A549 cells. J Gen Virol (2007) 1.16

Cell cycle arrest during measles virus infection: a G0-like block leads to suppression of retinoblastoma protein expression. J Virol (1999) 1.16

Herpes simplex virus 1 regulatory protein ICP22 interacts with a new cell cycle-regulated factor and accumulates in a cell cycle-dependent fashion in infected cells. J Virol (1998) 1.14

Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus. Mol Cell Proteomics (2010) 1.14

A 3-D well-differentiated model of pediatric bronchial epithelium demonstrates unstimulated morphological differences between asthmatic and nonasthmatic cells. Pediatr Res (2010) 1.13

Murine coronavirus replication induces cell cycle arrest in G0/G1 phase. J Virol (2004) 1.10

Aberrant cell cycle and apoptotic changes characterise severe influenza A infection--a meta-analysis of genomic signatures in circulating leukocytes. PLoS One (2011) 1.09

Cell cycle arrest rather than apoptosis is associated with measles virus contact-mediated immunosuppression in vitro. J Gen Virol (1997) 1.08

Cell cycle arrest by transforming growth factor beta1 enhances replication of respiratory syncytial virus in lung epithelial cells. J Virol (2009) 1.07

The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis. J Virol (2008) 1.04

Respiratory syncytial virus decreases p53 protein to prolong survival of airway epithelial cells. J Immunol (2007) 1.04

HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication. Proc Natl Acad Sci U S A (2010) 1.03

Measles virus-induced immunosuppression in vitro is associated with deregulation of G1 cell cycle control proteins. J Gen Virol (1999) 0.99

Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks. Virology (2005) 0.99

Cell cycle perturbations induced by infection with the coronavirus infectious bronchitis virus and their effect on virus replication. J Virol (2006) 0.98

Measles virus nucleoprotein induces cell-proliferation arrest and apoptosis through NTAIL-NR and NCORE-FcgammaRIIB1 interactions, respectively. J Gen Virol (2005) 0.97

Cell cycle arrest and apoptosis induced by the coronavirus infectious bronchitis virus in the absence of p53. Virology (2007) 0.97

Measles virus-induced immunosuppression in cotton rats is associated with cell cycle retardation in uninfected lymphocytes. J Gen Virol (1999) 0.95

Cytopathogenesis of Sendai virus in well-differentiated primary pediatric bronchial epithelial cells. J Virol (2010) 0.91

Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus subgroup B using SILAC coupled to LC-MS/MS. Proteomics (2010) 0.88

Differential regulation of cyclin D1 and D2 in protecting against cardiomyocyte proliferation. Cell Cycle (2008) 0.84

Cell cycle dependent nucleolar localization of the coronavirus nucleocapsid protein. Cell Cycle (2007) 0.82

Characterisation of cyclin D1 down-regulation in coronavirus infected cells. FEBS Lett (2007) 0.81

Human respiratory syncytial virus reduces the number of cells in S-phase and increases GADD153 expression in HEp-2 cells. Acta Virol (2009) 0.80

Articles by these authors

Heterogeneous duplications in patients with Pelizaeus-Merzbacher disease suggest a mechanism of coupled homologous and nonhomologous recombination. Am J Hum Genet (2005) 1.95

Nucleolar targeting: the hub of the matter. EMBO Rep (2009) 1.82

Recent advances in the molecular and cellular biology of bunyaviruses. J Gen Virol (2011) 1.76

Changes in superior mesenteric artery blood flow after oral, enteral, and parenteral feeding in humans. Crit Care Med (2009) 1.50

Random mutagenesis of proximal mouse chromosome 5 uncovers predominantly embryonic lethal mutations. Genome Res (2005) 1.30

Effects of foot-and-mouth disease virus nonstructural proteins on the structure and function of the early secretory pathway: 2BC but not 3A blocks endoplasmic reticulum-to-Golgi transport. J Virol (2005) 1.27

Structure, function, and evolution of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein. J Virol (2012) 1.26

Investigating the specificity and stoichiometry of RNA binding by the nucleocapsid protein of Bunyamwera virus. RNA (2009) 1.14

Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus. Mol Cell Proteomics (2010) 1.14

Inhibition of the secretory pathway by foot-and-mouth disease virus 2BC protein is reproduced by coexpression of 2B with 2C, and the site of inhibition is determined by the subcellular location of 2C. J Virol (2006) 1.10

Nucleocapsid protein structures from orthobunyaviruses reveal insight into ribonucleoprotein architecture and RNA polymerization. Nucleic Acids Res (2013) 1.09

Fas-Fas ligand interactions are essential for the binding to and killing of activated macrophages by gamma delta T cells. J Immunol (2004) 1.08

Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein. J Gen Virol (2005) 1.07

Intraepithelial gammadelta+ lymphocytes maintain the integrity of intestinal epithelial tight junctions in response to infection. Gastroenterology (2006) 1.07

Interaction of the coronavirus nucleoprotein with nucleolar antigens and the host cell. J Virol (2002) 1.06

Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity. Genome Biol (2014) 1.01

Direct visualization of the small hydrophobic protein of human respiratory syncytial virus reveals the structural basis for membrane permeability. FEBS Lett (2010) 1.00

Identification of an upstream sequence element required for vesicular stomatitis virus mRNA transcription. J Virol (2002) 1.00

Quantitative proteomics using stable isotope labeling with amino acids in cell culture reveals changes in the cytoplasmic, nuclear, and nucleolar proteomes in Vero cells infected with the coronavirus infectious bronchitis virus. Mol Cell Proteomics (2010) 1.00

Using SILAC and quantitative proteomics to investigate the interactions between viral and host proteomes. Proteomics (2012) 1.00

Elucidation of the Ebola virus VP24 cellular interactome and disruption of virus biology through targeted inhibition of host-cell protein function. J Proteome Res (2014) 0.99

Purification, crystallization and preliminary X-ray crystallographic analysis of the nucleocapsid protein of Bunyamwera virus. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.99

Cell cycle perturbations induced by infection with the coronavirus infectious bronchitis virus and their effect on virus replication. J Virol (2006) 0.98

Crystal structure of the essential transcription antiterminator M2-1 protein of human respiratory syncytial virus and implications of its phosphorylation. Proc Natl Acad Sci U S A (2014) 0.96

Delineation and modelling of a nucleolar retention signal in the coronavirus nucleocapsid protein. Traffic (2006) 0.96

Quantitative proteomics using SILAC coupled to LC-MS/MS reveals changes in the nucleolar proteome in influenza A virus-infected cells. J Proteome Res (2010) 0.95

The asymmetric structure of an icosahedral virus bound to its receptor suggests a mechanism for genome release. Structure (2013) 0.95

A quantitative proteomic analysis of lung epithelial (A549) cells infected with 2009 pandemic influenza A virus using stable isotope labelling with amino acids in cell culture. Proteomics (2012) 0.95

Effects of a point mutation in the 3' end of the S genome segment of naturally occurring and engineered Bunyamwera viruses. J Gen Virol (2003) 0.94

The interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biology. J Virol (2012) 0.94

Mass spectroscopic characterization of the coronavirus infectious bronchitis virus nucleoprotein and elucidation of the role of phosphorylation in RNA binding by using surface plasmon resonance. J Virol (2005) 0.93

High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitors. J Virol (2012) 0.92

Evaluation of a nucleoprotein-based enzyme-linked immunosorbent assay for the detection of antibodies against infectious bronchitis virus. Avian Pathol (2003) 0.92

Rapid dendritic cell mobilization to the large intestinal epithelium is associated with resistance to Trichuris muris infection. J Immunol (2009) 0.91

Amino acid changes within the Bunyamwera virus nucleocapsid protein differentially affect the mRNA transcription and RNA replication activities of assembled ribonucleoprotein templates. J Gen Virol (2010) 0.91

The cellular interactome of the coronavirus infectious bronchitis virus nucleocapsid protein and functional implications for virus biology. J Virol (2013) 0.90

Changes in nucleolar morphology and proteins during infection with the coronavirus infectious bronchitis virus. Cell Microbiol (2006) 0.90

Characterisation of the RNA binding properties of the coronavirus infectious bronchitis virus nucleocapsid protein amino-terminal region. FEBS Lett (2006) 0.90

Viral nucleolar localisation signals determine dynamic trafficking within the nucleolus. Virology (2008) 0.89

ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci (2004) 0.89

Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus subgroup B using SILAC coupled to LC-MS/MS. Proteomics (2010) 0.88

An interactome map of the nucleocapsid protein from a highly pathogenic North American porcine reproductive and respiratory syndrome virus strain generated using SILAC-based quantitative proteomics. Proteomics (2012) 0.88

Lithium chloride inhibits the coronavirus infectious bronchitis virus in cell culture. Avian Pathol (2007) 0.86

Nucleolin is regulated both at the level of transcription and translation. Biochem Biophys Res Commun (2005) 0.85

Missing optomotor head-turning reflex in the DBA/2J mouse. Invest Ophthalmol Vis Sci (2011) 0.85

The cell cycle and virus infection. Methods Mol Biol (2005) 0.85

Elucidation of the avian nucleolar proteome by quantitative proteomics using SILAC and changes in cells infected with the coronavirus infectious bronchitis virus. Proteomics (2010) 0.84

Trafficking motifs in the SARS-coronavirus nucleocapsid protein. Biochem Biophys Res Commun (2007) 0.82

Cell cycle dependent nucleolar localization of the coronavirus nucleocapsid protein. Cell Cycle (2007) 0.82

Low glutathione regulates gene expression and the redox potentials of the nucleus and cytosol in Arabidopsis thaliana. Plant Cell Environ (2014) 0.82

Selection for gene junction sequences important for VSV transcription. Virology (2008) 0.81

Characterisation of cyclin D1 down-regulation in coronavirus infected cells. FEBS Lett (2007) 0.81

PK-15 cells transfected with porcine CD163 by PiggyBac transposon system are susceptible to porcine reproductive and respiratory syndrome virus. J Virol Methods (2013) 0.80

Bunyamwera virus can repair both insertions and deletions during RNA replication. RNA (2010) 0.79

Biophysical characterisation of the nucleocapsid protein from a highly pathogenic porcine reproductive and respiratory syndrome virus strain. Biochem Biophys Res Commun (2012) 0.79

Characterization of antigenic domains and epitopes in the ORF3 protein of a Chinese isolate of avian hepatitis E virus. Vet Microbiol (2013) 0.79

Characterization of the nuclear export signal in the coronavirus infectious bronchitis virus nucleocapsid protein. J Virol (2007) 0.79

Role of phosphorylation clusters in the biology of the coronavirus infectious bronchitis virus nucleocapsid protein. Virology (2007) 0.79

Infectious bronchitis coronavirus induces cell-cycle perturbations. Adv Exp Med Biol (2006) 0.78

Probing bunyavirus N protein oligomerisation using mass spectrometry. Rapid Commun Mass Spectrom (2014) 0.77

Three-dimensional reconstruction of the nucleolus using meta-confocal microscopy in cells expressing the coronavirus nucleoprotein. Adv Exp Med Biol (2006) 0.77

Anti-idiotypic antibodies reduce efficacy of the attenuated vaccine against highly pathogenic PRRSV challenge. BMC Vet Res (2014) 0.77

A model for the dynamic nuclear/nucleolar/cytoplasmic trafficking of the porcine reproductive and respiratory syndrome virus (PRRSV) nucleocapsid protein based on live cell imaging. Virology (2008) 0.77

Expression and structural analysis of infectious bronchitis virus nucleoprotein. Adv Exp Med Biol (2006) 0.77

Different NF-κB activation characteristics of human respiratory syncytial virus subgroups A and B. Microb Pathog (2011) 0.76

Recombinant viral proteins for use in diagnostic ELISAs to detect virus infection. Vaccine (2007) 0.75

Proteomic analysis of mitochondria in respiratory epithelial cells infected with human respiratory syncytial virus and functional implications for virus and cell biology. J Pharm Pharmacol (2014) 0.75